SMi is proud to have Tine Bryan Stensbøl, Divisional Director Discovery Pharmacology Research from Lundbeck, presenting at its 13th annual Clinical Trials in CNS Conference. She will be discussing the new frontiers in Schizophrenia research, how the understanding of this condition has progressed in the past 5 years and what opportunities lie for the future.

With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society. With this comes the need for new and improved therapies for treating neurodegenerative conditions.

This conference will give delegates the opportunity to gain additional insights into the best practices in clinical trials, as well as address the challenges in CNS research and by looking at the latest pre-clinical and clinical studies.

This is an opportunity not to be missed, as we delve into the complex and exciting world of Central Nervous System discovery, allowing delegates to learn, explore and debate the key areas of CNS, its preclinical discovery and its clinical trials.

Reasons to Attend:

  • Examine the multi-stakeholder approach to self-management and multidisciplinary care in patients with MS
  • Discuss the past, present and future of CNS medicines research
  • Analyse novel biomarkers for the brain
  • Understand the recent failures in CNS development and how translation did not work
  • Review the collaboration between industry and academic partnering

    • Key Speakers:

    • Tine Bryan Stensbøl, Divisional Director Discovery Pharmacology Research, Lundbeck
    • Alan Palmer, Co-Founder and Director, MS Therapeutics
    • Veronique Bragulat, Clinical Imaging Manager, GSK
    • Sophie Dix, Senior Research Scientist, Neurodegenerative Disease Drug Hunting Team, Eli Lilly
    • David Willé, Applied Statistician, GSK
    • Peter Joseph Jongen, Founding Director, MS4 Research Institute
    • Ernst-Wilhelm Radue, CEO, MIAC AG
    • Edwin Johnson, Director, Stockholm Brain Institute
    • Shahid Zaman, Affiliated Lecturer, University of Cambridge

    For more information please visit www.smi-online.co.uk/2014clinicaltrialscns72.asp

    If you would like to attend this conference as a delegate please contact Filipa Ribeiro on +44 (0) 207 827 6020 or e-mail fribeiro@smi-online.co.uk

    If you are interested in sponsoring this event contact Alia Malick on +44(0)20 7827 6168 or email amalick@smi-online.co.uk

    If you would like to become a media partner contact Sarah Watson on +44 (0)20 7827 6134 or email swatson@smi-online.co.uk